{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:08:34Z","timestamp":1789664914833,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>Elderly patients with community-acquired pneumonia (CAP) are a common infectious disease group, particularly with a high incidence in the elderly population. With the aging of society, the management of elderly CAP patients faces greater challenges. Elderly CAP patients are often accompanied by cardiovascular diseases, and the incidence of secondary cardiovascular events is high, severely affecting their clinical prognosis. Therefore, identifying risk factors for secondary cardiovascular events and exploring their impact on patient prognosis is of great significance for improving treatment outcomes. This study retrospectively analyzed 110 elderly CAP patients admitted from January 2023 to January 2024, divided into an event group (n\u2005=\u200545) and a non-event group (n\u2005=\u200565) based on the occurrence of secondary cardiovascular events. Basic clinical data were collected, and the relationship between advanced age, smoking history, hypertension, diabetes, and inflammatory markers (C-reactive protein and neutrophil\/lymphocyte ratio) and secondary cardiovascular events was analyzed. Univariate and multivariate logistic regression analyses were used to assess the impact of various factors on cardiovascular events, and a 12-month follow-up was conducted to evaluate their effect on clinical prognosis. The event group had significantly higher average age, smoking history, and incidence of hypertension and diabetes than the non-event group. The incidence of secondary cardiovascular events was 40.9%, with heart failure accounting for 42.2%, acute myocardial infarction for 26.7%, and arrhythmia for 31.1%. Advanced age (odds ratio [OR]\u2005=\u20051.45, 95% confidence interval [CI]: 1.12\u20131.88), hypertension (OR\u2005=\u20051.76, 95% CI: 1.21\u20132.57), and diabetes (OR\u2005=\u20051.69, 95% CI: 1.14\u20132.48) were independent risk factors for secondary cardiovascular events. The levels of C-reactive protein and neutrophil\/lymphocyte ratio were significantly higher in the event group compared to the non-event group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The all-cause mortality rate for the secondary cardiovascular event group was 24.4%, and the readmission rate was 37.8%, significantly higher than that of the non-event group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The area under the curve of the multivariate regression model was 0.82, indicating good predictive ability. Advanced age, smoking history, hypertension, diabetes, and inflammatory responses are independent risk factors for secondary cardiovascular events in elderly CAP patients, and secondary cardiovascular events significantly impact clinical prognosis. Clinical efforts should focus on identifying and intervening in high-risk factors to reduce the occurrence of secondary cardiovascular events.<\/jats:p>","DOI":"10.1097\/md.0000000000043316","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:47Z","timestamp":1754089307000},"page":"e43316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective study on cardiovascular risks and prognosis in elderly patients with community-acquired pneumonia"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9801-5855","authenticated-orcid":false,"given":"Linlin","family":"Huang","sequence":"first","affiliation":[{"name":"General Medicine Department, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Image Center, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Zhang","sequence":"additional","affiliation":[{"name":"General Medicine Department, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Tian","sequence":"additional","affiliation":[{"name":"General Medicine Department, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Fifth Affiliated (Zhuhai) Hospital of Zunyi Medical University, Zhuhai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14760584.2023.2261785","article-title":"Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.","volume":"22","author":"Tsoumani","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"11038","DOI":"10.3390\/ijms241311038","article-title":"The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular events, with a focus on pneumolysin and macrolide antibiotics in pathogenesis and therapy.","volume":"24","author":"Anderson","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia.","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/joim.12875","article-title":"Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia.","volume":"285","author":"Feldman","year":"2019","journal-title":"J Intern Med"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/microorganisms10112177","article-title":"Cardiovascular complications in community-acquired pneumonia.","volume":"10","author":"Desai","year":"2022","journal-title":"Microorganisms"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/rccm.202308-1321OC","article-title":"The plasma lipidomic landscape in patients with sepsis due to community-acquired pneumonia.","volume":"209","author":"Chouchane","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/09031936.00049111","article-title":"Is community-acquired pneumonia an independent risk factor for cardiovascular disease?","volume":"39","author":"Singanayagam","year":"2012","journal-title":"Eur Respir J"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-016-0011-0","article-title":"Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia.","volume":"8","author":"Feldman","year":"2016","journal-title":"Pneumonia (Nathan)"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"e017645","DOI":"10.1161\/JAHA.120.017645","article-title":"Community-acquired pneumonia and risk of cardiovascular events in people living with HIV.","volume":"9","author":"Zifodya","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jinf.2023.11.010","article-title":"Low-grade endotoxemia is associated with cardiovascular events in community-acquired pneumonia.","volume":"88","author":"Cangemi","year":"2024","journal-title":"J Infect"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.chest.2019.06.040","article-title":"Community-acquired pneumonia patients at risk for early and long-term cardiovascular events are identified by cardiac biomarkers.","volume":"156","author":"Men\u00e9ndez","year":"2019","journal-title":"Chest"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.chest.2022.11.013","article-title":"Cardiovascular complications are the primary drivers of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia.","volume":"163","author":"Ali","year":"2023","journal-title":"Chest"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12879-021-05781-w","article-title":"Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study [published correction appears in BMC Infect Dis. 2021 Feb 19;21(1):195. doi: 10.1186\/s12879-021-05891-5.].","volume":"21","author":"Pieralli","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2013.12.001","article-title":"The management of community-acquired pneumonia in the elderly.","volume":"25","author":"Faverio","year":"2014","journal-title":"Eur J Intern Med"},{"key":"R15-20250918","first-page":"473","article-title":"Treatment options for community-acquired pneumonia in the elderly people.","volume":"13","author":"Petrosillo","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2018.08.022","article-title":"Diagnostic value of blood parameters for community-acquired pneumonia.","volume":"64","author":"Huang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"f1235","DOI":"10.1136\/bmj.f1235","article-title":"Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.","volume":"346","author":"Schembri","year":"2013","journal-title":"BMJ"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: a randomized clinical trial.","volume":"326","author":"Estcourt","year":"2021","journal-title":"JAMA"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s10238-023-01101-5","article-title":"The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open-label, randomised controlled trial.","volume":"23","author":"van Zijverden","year":"2023","journal-title":"Clin Exp Med"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"1351492","DOI":"10.3389\/fmed.2024.1351492","article-title":"Clinical predictive value of the initial neutrophils to lymphocytes and platelets ratio for prognosis of sepsis patients in the intensive care unit: a retrospective study.","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"106714","DOI":"10.1016\/j.rmed.2021.106714","article-title":"Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.","volume":"191","author":"Sheikh","year":"2022","journal-title":"Respir Med"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11739-019-02117-0","article-title":"Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial.","volume":"15","author":"Violi","year":"2020","journal-title":"Intern Emerg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:02:58Z","timestamp":1758232978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":22,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043316","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}